Adagio Medical Holdings (ADGM) Return on Capital Employed (2025 - 2026)

Adagio Medical Holdings (ADGM) reported Return on Capital Employed of 59.94% for Q1 2026, up 1025.0% year-over-year from 5.33% in Q1 2025, and up 19.81% quarter-over-quarter from 74.75% in Q4 2025.

Adagio Medical Holdings (ADGM) Return on Capital Employed (2025 - 2026) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Return on Capital Employed data on file, last reported at 59.94% in Q1 2026.

  • Return on Capital Employed for Q1 2026 came in at 59.94%, up 1025.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 59.94% (up 1025.0% YoY), and the FY2025 annual result was 58.19%, up 25620.0% from the prior year.
  • Return on Capital Employed rose to 59.94% in Q1 2026 per ADGM's latest filing, from 74.75% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 59.94% in Q1 2026 and troughed at 92.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.61%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.24%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 7.36%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 10.45%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 9.30%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 11.57%
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn - -59.94%

Historic Data

Download Data
DateValue
Mar 31, 2026 -59.94%
Dec 31, 2025 -74.75%
Sep 30, 2025 -92.72%
Jun 30, 2025 -68.79%
Mar 31, 2025 -70.19%